311 related articles for article (PubMed ID: 34480040)
1. Quantification of dynamic contrast-enhanced ultrasound (CEUS) in non-cystic breast lesions using external perfusion software.
Jung EM; Jung F; Stroszczynski C; Wiesinger I
Sci Rep; 2021 Sep; 11(1):17677. PubMed ID: 34480040
[TBL] [Abstract][Full Text] [Related]
2. VueBox® perfusion analysis of dynamic contrast enhanced ultrasound provides added value in the diagnosis of small thyroid nodules.
Huang Y; Wang Y; Liu L; Zhu L; Qiu Y; Zuo D; Lu X; Dong Y; Jung EM; Wang W
Clin Hemorheol Microcirc; 2023; 83(4):409-420. PubMed ID: 36683500
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of contrast-enhanced ultrasound of breast BI-RADS 3-5 lesions.
Janu E; Krikavova L; Little J; Dvorak K; Brancikova D; Jandakova E; Pavlik T; Kovalcikova P; Kazda T; Valek V
BMC Med Imaging; 2020 Jun; 20(1):66. PubMed ID: 32552678
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Treatment of Malignant Liver Lesions: Evaluation of Success Using Contrast- Enhanced Ultrasound (CEUS) and Perfusion Software.
Wiesinger I; Wiggermann P; Zausig N; Beyer LP; Salzberger B; Stroszczynski C; Jung EM
Ultraschall Med; 2018 Aug; 39(4):440-447. PubMed ID: 28946152
[TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions.
Zhao H; Xu R; Ouyang Q; Chen L; Dong B; Huihua Y
Eur J Radiol; 2010 Feb; 73(2):288-93. PubMed ID: 19559551
[TBL] [Abstract][Full Text] [Related]
6. Color Coded Perfusion Imaging with Contrast Enhanced Ultrasound (CEUS) for Post-Interventional Success Control Following Irreversible Electroporation (IRE) of Primary and Secondary Malignant Liver Lesions.
Rennert J; Wiesinger I; Schicho A; Wiggermann P; Stroszczynski C; Beyer LP; Jung EM
J Gastrointestin Liver Dis; 2019 Sep; 28(3):311-318. PubMed ID: 31517328
[TBL] [Abstract][Full Text] [Related]
7. Color coded perfusion analysis and microcirculation imaging with contrast enhanced ultrasound (CEUS) for post-interventional success control following thermal ablative techniques of primary and secondary liver malignancies.
Rennert J; Wiesinger I; Beyer LP; Schicho A; Stroszczynski C; Wiggermann P; Jung EM
Clin Hemorheol Microcirc; 2019; 73(1):73-83. PubMed ID: 31561352
[TBL] [Abstract][Full Text] [Related]
8. VueBox® perfusion analysis of contrast-enhanced ultrasound (CEUS) examinations in patients with primary hyperparathyroidism for preoperative detection of parathyroid gland adenoma.
Platz Batista da Silva N; Jung EM; Jung F; Schlitt HJ; Hornung M
Clin Hemorheol Microcirc; 2018; 70(4):423-431. PubMed ID: 30347604
[TBL] [Abstract][Full Text] [Related]
9. Contrast enhanced ultrasound (CEUS) with parametric imaging and time intensity curve analysis (TIC) for evaluation of the success of prostate arterial embolization (PAE) in cases of prostate hyperplasia.
Jung EM; Wertheimer T; Putz FJ; Jung F; Kammerer S; Pregler B; Luerken L; Stroszczynski C; Beyer L
Clin Hemorheol Microcirc; 2020; 76(2):143-153. PubMed ID: 32925006
[TBL] [Abstract][Full Text] [Related]
10. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging.
Ricci P; Cantisani V; Ballesio L; Pagliara E; Sallusti E; Drudi FM; Trippa F; Calascibetta F; Erturk SM; Modesti M; Passariello R
Ultraschall Med; 2007 Feb; 28(1):57-62. PubMed ID: 17304413
[TBL] [Abstract][Full Text] [Related]
11. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
Du YR; Wu Y; Chen M; Gu XG
Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
[TBL] [Abstract][Full Text] [Related]
12. Can different regions of interest influence the diagnosis of benign and malignant breast lesions using quantitative parameters of contrast-enhanced sonography?
Li J; Guo L; Yin L; Fang H; Ye W; Zhao B; Liu Y; Xu T
Eur J Radiol; 2018 Nov; 108():1-6. PubMed ID: 30396640
[TBL] [Abstract][Full Text] [Related]
13. [Value of contrast-enhanced sonography in early diagnosis of breast cancer].
Cai L; Zhang J; Song G; Chen L; Dai J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Dec; 33(12):1801-5. PubMed ID: 24369249
[TBL] [Abstract][Full Text] [Related]
14. The diagnostic value of contrast-enhanced ultrasonography in breast ductal abnormalities.
Wang B; Yang D; Zhang X; Gong X; Xu T; Han J; Ren Y; Zou S; Li L; Wang Y
Cancer Imaging; 2023 Mar; 23(1):25. PubMed ID: 36899406
[TBL] [Abstract][Full Text] [Related]
15. Qualitative, quantitative and combination score systems in differential diagnosis of breast lesions by contrast-enhanced ultrasound.
Wang Y; Fan W; Zhao S; Zhang K; Zhang L; Zhang P; Ma R
Eur J Radiol; 2016 Jan; 85(1):48-54. PubMed ID: 26724648
[TBL] [Abstract][Full Text] [Related]
16. First results of endocavity evaluation of the microvascularization of malignant prostate tumors using contrast enhanced ultrasound (CEUS) including perfusion analysis: first results.
Jung EM; Wiggermann P; Greis C; Eder F; Ehrich J; Jung W; Schreyer AG; Stroszczynski C; Ganzer R
Clin Hemorheol Microcirc; 2012; 52(2-4):167-77. PubMed ID: 22975940
[TBL] [Abstract][Full Text] [Related]
17. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
18. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
[TBL] [Abstract][Full Text] [Related]
19. Analysis of arterial dynamic micro-vascularization with contrast-enhanced ultrasound (CEUS) in thyroid lesions using external perfusion software: First results.
Wiesinger I; Kroiss E; Zausig N; Hornung M; Zeman F; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2016; 64(4):747-755. PubMed ID: 27792004
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between benign and malignant breast tumors using kinetic features of real-time harmonic contrast-enhanced ultrasound.
Saracco A; Szabó BK; Aspelin P; Leifland K; Wilczek B; Celebioglu F; Axelsson R
Acta Radiol; 2012 May; 53(4):382-8. PubMed ID: 22434928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
